Axonics, Inc. (AXNX)

73.74 +1.36 (+1.88%) At close: 04:00PM EDT

Axonics, Inc.

26 Technology Drive
Irvine, CA 92618
United States
949 396 6322
https://www.axonics.com

Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 517

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Raymond W. Cohen	CEO & Director	1.34M	N/A	1959
Mr. Danny L. Dearen	Pres & CFO	790.2k	3.69M	1963
Mr. Rinda K. Sama	Chief Operating Officer	758.6k	736.11k	1980
Dr. John Woock Ph.D.	Exec. VP, Chief Marketing & Strategy Officer	586.35k	599.57k	1984
Mr. Alfred J. Ford Jr.	Chief Commercial Officer	585.99k	2.24M	1971
Mr. Guangqiang Jiang Ph.D.	Chief Technology Officer	N/A	N/A	1974
Mr. Neil Bhalodkar	VP of Investor Relations	N/A	N/A	N/A
Mr. Aaron Pettit	Gen. Counsel & Chief Compliance Officer	N/A	N/A	N/A
Mr. Michael V. Williamson Esq., J.D.	Sr. VP, Gen. & IP Counsel	N/A	N/A	1972
Dr. Karen L. Noblett M.A.S., M.D.	Chief Medical Officer	N/A	N/A	1964

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California.

Corporate Governance

Axonics, Inc.’s ISS Governance QualityScore as of July 1, 2022 is 4. The pillar scores are Audit: 10; Board: 5; Shareholder Rights: 4; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.